Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
- PMID: 24092460
- PMCID: PMC3976843
- DOI: 10.1007/s11682-013-9262-z
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
Abstract
The Genetics Core of the Alzheimer's Disease Neuroimaging Initiative (ADNI), formally established in 2009, aims to provide resources and facilitate research related to genetic predictors of multidimensional Alzheimer's disease (AD)-related phenotypes. Here, we provide a systematic review of genetic studies published between 2009 and 2012 where either ADNI APOE genotype or genome-wide association study (GWAS) data were used. We review and synthesize ADNI genetic associations with disease status or quantitative disease endophenotypes including structural and functional neuroimaging, fluid biomarker assays, and cognitive performance. We also discuss the diverse analytical strategies used in these studies, including univariate and multivariate analysis, meta-analysis, pathway analysis, and interaction and network analysis. Finally, we perform pathway and network enrichment analyses of these ADNI genetic associations to highlight key mechanisms that may drive disease onset and trajectory. Major ADNI findings included all the top 10 AD genes and several of these (e.g., APOE, BIN1, CLU, CR1, and PICALM) were corroborated by ADNI imaging, fluid and cognitive phenotypes. ADNI imaging genetics studies discovered novel findings (e.g., FRMD6) that were later replicated on different data sets. Several other genes (e.g., APOC1, FTO, GRIN2B, MAGI2, and TOMM40) were associated with multiple ADNI phenotypes, warranting further investigation on other data sets. The broad availability and wide scope of ADNI genetic and phenotypic data has advanced our understanding of the genetic basis of AD and has nominated novel targets for future studies employing next-generation sequencing and convergent multi-omics approaches, and for clinical drug and biomarker development.
Figures
References
-
- Antunez C, Boada M, Lopez-Arrieta J, Moreno-Rey C, Hernandez I, Marin J, et al. Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer’s disease. Alzheimers Dement. 2011;7(4):e124–e129. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K01 AG030514/AG/NIA NIH HHS/United States
- P41 EB015922/EB/NIBIB NIH HHS/United States
- R01 AG019771/AG/NIA NIH HHS/United States
- R01AG19771/AG/NIA NIH HHS/United States
- R01 AG042611/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- U01AG024904/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- R01 LM011360/LM/NLM NIH HHS/United States
- NS080655/NS/NINDS NIH HHS/United States
- R01 LM010098/LM/NLM NIH HHS/United States
- K99LM011384/LM/NLM NIH HHS/United States
- R01 LM009012/LM/NLM NIH HHS/United States
- 9 P41EB015922-15/EB/NIBIB NIH HHS/United States
- U24 RR21992/RR/NCRR NIH HHS/United States
- R00 LM011384/LM/NLM NIH HHS/United States
- MH097268/MH/NIMH NIH HHS/United States
- P30 AG10133/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- U24 AG021886/AG/NIA NIH HHS/United States
- K99 LM011384/LM/NLM NIH HHS/United States
- R01 AG040060/AG/NIA NIH HHS/United States
- HD050735/HD/NICHD NIH HHS/United States
- U24RR025736/RR/NCRR NIH HHS/United States
- RC2 AG036535/AG/NIA NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- R01 HD050735/HD/NICHD NIH HHS/United States
- K24 AG027841/AG/NIA NIH HHS/United States
- R01 HG002213/HG/NHGRI NIH HHS/United States
- U24 RR021992/RR/NCRR NIH HHS/United States
- R01 NS080655/NS/NINDS NIH HHS/United States
- R01 MH097268/MH/NIMH NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- U24 RR025736/RR/NCRR NIH HHS/United States
- AG040060/AG/NIA NIH HHS/United States
- P60 DA011015/DA/NIDA NIH HHS/United States
- AG036535/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
